RXO Valuation

RXO Inc

Add to Watchlist

Advanced Chart

17.420

+0.42(2.471%)1D

Overview
Forecast
Valuation
Earnings

RXO Relative Valuation

RXO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, RXO is overvalued; if below, it's undervalued.

Historical Valuation

RXO Inc (RXO) is now in the Overvalued zone, suggesting that its current forward PE ratio of 86.07 is considered Overvalued compared with the five-year average of 61.25. The fair price of RXO Inc (RXO) is between 8.34 to 14.61 according to relative valuation methord. Compared to the current price of 17.42 USD , RXO Inc is Overvalued By 19.21%.

Relative Value

Fair Zone

8.34-14.61

Current Price：17.42

19.21%

Overvalued

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

1.80

P/B

Median3y

3.56

Median5y

3.56

-2.51

FCF Yield

Median3y

2.90

Median5y

2.90

Competitors Valuation Multiple

The average P/S ratio for RXO's competitors is 4.96, providing a benchmark for relative valuation. RXO Inc Corp (RXO) exhibits a P/S ratio of 0.46, which is -90.82% above the industry average. Given its robust revenue growth of 56.96%, this premium appears sustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap